Eucrates Biomedical Acquisition Corp. Annual Net Income (Loss) Attributable to Parent in USD from 2021 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Eucrates Biomedical Acquisition Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2021 to 2022.
  • Eucrates Biomedical Acquisition Corp. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2022 was $142K, a 43.1% decline year-over-year.
  • Eucrates Biomedical Acquisition Corp. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2022 was $2.42M, a 36.7% decline year-over-year.
  • Eucrates Biomedical Acquisition Corp. annual Net Income (Loss) Attributable to Parent for 2022 was $2.42M, a 36.7% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.42M -$1.4M -36.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-13
2021 $3.82M Jan 1, 2021 Dec 31, 2021 10-K 2023-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.